Myology research highlights

RSS feed

Systemic injection of an optimized antisense oligonucleotide into an FSH mouse model appears to be effective

Facioscapulohumeral dystrophy (FSH) is one of the most common myopathies. There are two forms, FSH1 and FSH2. In both cases, the DUX4 gene is abnormally expressed in the muscles.  In an effort to inhibit DUX4, Canadian researchers have optimized antisense oligonucleotides by coupling them to a peptide that favors their penetration into muscle cells. This optimized … [Read more]

A catalog of sodium channel variants to guide in the diagnosis of certain myotonic syndromes

An international consortium of researchers has catagorized, based on literature data, the biophysical and genetic characteristics of 437 sodium channel variants known to date (including the sodium channel encoded by the SCN4A gene): 79 of them were related to a muscular phenotype (corresponding to a myotonic syndrome in most cases), 141 variants corresponded to epileptic … [Read more]

An innovative test for the genotyping of difficult cases of DMD and a better pathophysiological approach

Italian researchers have developed, in conjunction with the Perkin-Elmer laboratory, a test based on RNA sequencing (RNA-seq) to detect and interpret the pathogenic nature of certain variants of the DMD gene encoding the dystrophin on simple urine samples: the test analyzes DMD gene transcripts present in stem cells detectable in small amounts in urine; the … [Read more]

Gastrointestinal motility disorders may accompany dermatomyositis

Publishing a study on a case, a team of Texan internists recalls the possibility of various digestive motor disorders in dermatomyositis: proximal dysphagia (pharynx and upper third of the esophagus), relatively common in inflammatory myopathies (25 to 50% of cases), linked to damage to the striated muscles; distal dysphagia due to damage to smooth muscles, … [Read more]

No beneficial effect of resveratrol in fatty acid oxidation disorders

Resveratrol has been studied in a randomized, placebo-controlled, cross-over clinical trial. Organized jointly by French, Danish and Dutch, the study aimed to measure possible positive effects in several fatty acid oxidation disorders, some of which have muscle expression (carnitine palmitoyltransferase type II or CPTII deficiency): eight patients participated in the study, which took place over … [Read more]

Positive anti-FHL1 antibodies in certain inflammatory myopathies

Australian and Swedish researchers have studied the immunological profile of patients with normal inflammatory myopathies (274) or scleroderma (174) and compared them with those of 100 control participants. The presence of autoantibodies directed against FHL1, a protein with four and a half LIM domains, already implicated in an X-linked hereditary myopathy, was more specifically sought. … [Read more]

A compilation of data on primary carnitine deficiencies

A review of the literature carried out by Dutch authors sheds light on the symptoms and signs, often disparate, associated with this metabolic disease discovered in 1973 and which, in certain countries, is the subject of screening. newborn: 757 patient observations were retained from 166 published articles; 20% had only a biochemical diagnosis which may … [Read more]

Update on hematological abnormalities in neuromuscular genetic pathologies

American researchers examined the presence and type of blood abnormalities existing in certain hereditary myopathies. These abnormalities may be of interest for the positive diagnosis, used as biomarkers, but also for the differential diagnosis. Anaemias, abnormalities of all kinds of white blood cells and thrombocytopenias are most often encountered. Many mitochondrial pathologies with muscular expression … [Read more]

Glucocorticoids more helpful for breathing than for the heart past loss of walking ability in DMD

American clinicians have been trying to find out if long-term corticosteroid therapy in DMD could be of any use in the non-ambulatory stage of the disease. Using data from 398 patients with DMD recruited through the MD STARnet network, they observed that: deterioration in left ventricular function was unaffected; respiratory function seemed to improve, with … [Read more]

Variety of practices in the cardiac management of patients with DMD

American cardio-paediatricians gathered within the ACTION network (Advanced Cardiac Therapies Improving Outcomes Network) were questioned about their management practices concerning DMD: 31 specialists from 23 separate institutions agreed to participate in the survey; while access to cardiac MRI and Holter monitoring is uniformly possible across the United States, their frequency and indications vary significantly from … [Read more]